NCT03384238 2026-03-17
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Stanford University
Phase 1/2 Recruiting
Stanford University
M.D. Anderson Cancer Center
Thomas Jefferson University
St. Antonius Hospital
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
Mayo Clinic